Performance
Day's Low
Day's High
₹411₹425.452 Week's Low
52 Week's High
₹355.45₹729.6
| Returns % | |
| 1 Month Return | + 1.95 % |
| 3 Month Return | -14.84 % |
| 1 Year Return | -40.52 % |
| Market Stats | |
| Previous Close | ₹419.70 |
| Open | ₹418.00 |
| Volume | 14.05K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹533.63Cr |
Key Statistics
| P/E Ratio | 83.28 |
| PEG Ratio | -11.95 |
| Market Cap | ₹533.63 Cr |
| P/B Ratio | 4.3 |
| EPS | 7.47 |
| Dividend Yield | 0.15 |
| Sector | Pharmaceuticals |
| ROE | 6.6 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹533.63 Cr | -4.88% | 0.56 | ₹9 Cr | ₹179 Cr | |
| BUY | ₹4,215.47 Cr | 7.77% | 0.63 | ₹94 Cr | ₹1,081 Cr | |
| NA | ₹521.96 Cr | 32.07% | 0.51 | NA | NA | |
| BUY | ₹11,736.94 Cr | 316.22% | 0.50 | ₹314 Cr | ₹2,177 Cr | |
| NA | ₹326.38 Cr | 145.42% | 0.66 | ₹5 Cr | ₹155 Cr |
Company Information
Share Price: ₹417.25 per share as on 06 Sep, 2024 04:01 PM
Market Capitalisation: ₹533.63Cr as of today
Revenue: ₹43.05Cr as on June 2024 (Q2 24)
Net Profit: ₹0.80Cr as on June 2024 (Q2 24)
Listing date: 27 Oct, 2021
Chairperson Name: Rahul Bishnoi
| Organisation | Medicamen Biotech Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Medicamen Biotech Ltd
Medicamen Biotech's Debt and Cash Position Raises Concerns - 04 Jul, 2024
Medicamen Biotech has ₹308.2m of debt, offset by ₹147.9m in cash, leading to net debt of about ₹160.3m. Its liabilities total ₹195.0m more than the combination of its cash and short-term receivables. While its low debt to EBITDA ratio suggests only modest use of debt, declining EBIT and burning a lot of cash over the last three years make its use of debt riskier.
Medicamen Biotech Q4 Net Sales Up 22.38% YoY, Quarterly Profit Down by 43.54% - 18 Jun, 2024
Medicamen Bio's net sales for March 2024 increased by 22.38% YoY to Rs. 47.32 crore, while quarterly net profit decreased by 43.54% YoY to Rs. 2.13 crore. The EPS has also decreased from Rs. 3.03 in March 2023 to Rs. 1.61 in March 2024. Medicamen Bio shares have given -15.60% returns over the last 6 months and -27.71% over the last 12 months.
Medicamen Biotech Q4 2023 Net Sales Up 21.16% YoY - 11 Jun, 2024
Medicamen Bio reported a 21.16% YoY increase in net sales for Q4 2023, with quarterly net profit at Rs. 3.10 crore, down 23.3% from the previous year. The company's EPS has decreased to Rs. 2.45 in March 2024 from Rs. 3.25 in March 2023. Medicamen Bio shares closed at 475.20 on June 10, 2024 (NSE) and have given -20.80% returns over the last 6 months and -28.28% over the last 12 months.
Insights on Medicamen Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 55.69% to 55.78% in Jun 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 80.6% return, outperforming this stock by 121.2%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 47.89 Cr → 43.63 Cr (in ₹), with an average decrease of 8.9% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 months, MEDICAMEQ stock has moved down by -14.8%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 2.4 Cr → 1.35 Cr (in ₹), with an average decrease of 23.9% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 43.21% to 42.99% in Jun 2024 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 0.11% to 0.06% in Jun 2024 quarter
Company Financials
Index Inclusions
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 42.99% | ||
| Foreign Institutions | 0.06% | ||
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 55.78% | 0.16 | |
| Others | 1.17% | 18.57 |
Key Indicators
Medicamen Biotech Ltd Valuation
Medicamen Biotech Ltd in the last 5 years
Lowest (41.41x)
March 13, 2024
Industry (59.14x)
September 6, 2024
Today (83.28x)
September 6, 2024
Highest (102.50x)
July 4, 2024
Earnings and Dividends
Medicamen Biotech Ltd Earnings Results
Medicamen Biotech Ltd’s net profit fell -67.7% since last year same period to ₹1.35Cr in the Q1 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated -36.62% fall in its net profits since last 3-months.
Read More about Earnings ResultsMedicamen Biotech Ltd Dividends May,2023
In the quarter ending March 2023, Medicamen Biotech Ltd has declared dividend of ₹1 - translating a dividend yield of 0.24%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Medicamen Biotech Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Medicamen Biotech Ltd shares.
Medicamen Biotech Ltd (MEDICAMEQ) share price today is ₹417.25
Medicamen Biotech Ltd is listed on NSE
Medicamen Biotech Ltd is listed on BSE
- Today’s highest price of Medicamen Biotech Ltd is ₹425.4.
- Today’s lowest price of Medicamen Biotech Ltd is ₹411.
PE Ratio of Medicamen Biotech Ltd is 83.28
PE ratio = Medicamen Biotech Ltd Market price per share / Medicamen Biotech Ltd Earnings per share
Today’s traded volume of Medicamen Biotech Ltd(MEDICAMEQ) is 14.05K.
Today’s market capitalisation of Medicamen Biotech Ltd(MEDICAMEQ) is ₹533.63Cr.
| Medicamen Biotech Ltd(MEDICAMEQ | Price |
|---|---|
52 Week High | ₹729.6 |
52 Week Low | ₹355.45 |
Medicamen Biotech Ltd(MEDICAMEQ) share price is ₹417.25. It is down -42.81% from its 52 Week High price of ₹729.6
Medicamen Biotech Ltd(MEDICAMEQ) share price is ₹417.25. It is up 17.39% from its 52 Week Low price of ₹355.45
| Medicamen Biotech Ltd(MEDICAMEQ | Returns |
|---|---|
1 Day Returns | -2.45% |
1 Month Returns | 1.95% |
3 Month Returns | -14.84% |
1 Year Returns | -40.52% |